Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 20, 2001

View Archived Issues

Available for licensing from NIH: T-cell epitopes from NY-ESO-1 cancer antigen

MAGE-12 T-cell epitope available for licensing from NIH

Important developments at Pharmacia during 2000

PhotoCure reports highlights from 2000 and goals for 2001

KS Biomedix and Aurelium BioPharma enter proteomics alliance

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

OraPharma's Arestin cleared for U.S. launch

Distribution agreement for Pacis BCG terminated by UroCor and BioChem Pharma

Cubist reports results for fourth quarter and full year

Antiangiogenic/antitumor compound TSRI-265 specifically disrupts MMP-2 binding to alphavbeta3

V-echinocandin has significant, dose-dependent efficacy against fluconazole-resistant OPEC

First report of in vivo efficacy of HNP-1 in experimental tuberculosis

Organometallic complexes with antiestrogenic and antiproliferative effects

Prescient NeuroPharma created following merger

Acute hemodynamic effects and safety of tezosentan in NYHA class III-IV CHF

Altace approved in Canada for expanded indication

Virulizin granted orphan drug status by FDA

Pilot trial of docosanol for AIDS-associated Kaposi's sarcoma

Protopic for severe atopic dermatitis launched in U.S.

Serono initiates trial of Serostim for HARS

Cancidas introduced following late January approval by FDA

U.S. and Israeli team prepares short peptides modulating serine/threonine kinase activity

New tuftsin analogues more potent than the parent compound and orally active

Aventis describes improved salt of known vitronectin antagonist useful in osteoporosis

Inhibitors of ileal bile acid transporter and use in hypercholesterolemia

Sankyo presents new cytokine production inhibitors in recent patent

Glutamate receptor antagonist prodrug with improved oral bioavailability in animals

Novel fused imidazoles for diabetes and complications thereof

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...